Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients-Reference-Cited by-同舟云学术

Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients

Published:2017-09-11 Issue:6 Volume:23 Page:e518-e523
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Chuansumrit A.¹^ORCID,Sasanakul W.¹,Sirachainan N.¹^ORCID,Kadegasem P.¹,Wongwerawattanakoon P.²,Mahaklan L.¹,Nathalang O.³

Affiliation:

1. Department of Pediatrics; Faculty of Medicine Ramathibodi Hospital; Mahidol University; Bangkok Thailand

2. Department of Nursing; Faculty of Medicine Ramathibodi Hospital; Mahidol University; Bangkok Thailand

3. Graduate Program; Faculty of Allied Health Sciences; Thammasat University; Pathumtani Thailand

Funder

Thailand Research Fund

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13344/fullpdf

Reference15 articles.

1. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs;Ehrenforth;Lancet,1992

2. Advances in the clinical management of inhibitors in hemophilia A and B and cost;Leissinger;Semin Hematol,2016

3. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group;Gringeri;Blood,2003

4. Polymorphisms in the IL10 but not in the IL 1beta and IL 4 genes are associated with inhibitor development in patients with hemophilia A;Astermark;Blood,2006

5. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A;Pavlova;J Thromb Haemost,2009